Free Trial
NYSEARCA:XPH

SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News

$48.05 +0.41 (+0.86%)
(As of 11/8/2024 ET)

About SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Key Stats

Today's Range
$47.31
$48.26
50-Day Range
$43.25
$48.05
52-Week Range
$34.67
$48.26
Volume
32,407 shs
Average Volume
41,030 shs
Market Capitalization
$233.04 million
Assets Under Management
$168.40 million
Dividend Yield
1.39%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

SPDR S&P Pharmaceuticals ETF Expenses

TypeXPHHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.57%0.55%0.51%0.52%
Other Expenses0.00%0.30%0.49%0.58%0.53%
Total Expense0.35%0.70%0.71%0.73%0.71%
Fee Waiver0.00%-0.45%-0.52%-0.67%-0.57%
Net Expense0.35%0.61%0.61%0.58%0.59%
Receive XPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

XPH ETF News Headlines

Trump’s Victory Just Kicked the Door Open to a…
This story is about a division that has been splitting America apart at the seams for the past three and a half years… Make no mistake, this division will definitely change YOUR financial future, for better or worse… That is why I’m sharing my post-election analysis of how this hidden division will impact your financial future…
SPDR S&P Pharmaceuticals ETF (XPH)
See More Headlines

XPH ETF - Frequently Asked Questions

SPDR S&P Pharmaceuticals ETF's stock was trading at $41.62 at the beginning of 2024. Since then, XPH stock has increased by 15.4% and is now trading at $48.05.
View the best growth stocks for 2024 here
.

SPDR S&P Pharmaceuticals ETF's top institutional shareholders include First Citizens Bank & Trust Co. (1.49%), MAI Capital Management (0.79%), PNC Financial Services Group Inc. (0.49%) and AlphaMark Advisors LLC (0.13%).

Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Pharmaceuticals ETF investors own include NVIDIA (NVDA), Pfizer (PFE), Adobe (ADBE), Applied Materials (AMAT), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Meta Platforms (META).

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:XPH
Inception Date
6/19/2006
Fund Manager
Michael Feehily, Karl Schneider, Keith Richardson

Fund Focus

Asset Class
Equity
Benchmark
S&P Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
50

Fund Statistics

Assets Under Management
$168.40 million
Average Daily Volume
$80,078.80
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
N/A
Short Interest
413,000 shs

Miscellaneous

Beta
0.87
Creation Unit
50,000
Creation Fee
$250.00
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Top 10 XPH Holdings

XPH Sector Exposure

XPH Industry Exposure


This page (NYSEARCA:XPH) was last updated on 11/10/2024 by MarketBeat.com Staff
From Our Partners